Skip to main content

Table 4 Relationship of clinical stage with PGF rs8019391 polymorphism in cervical cancer patients adjusted by age

From: Genetic polymorphisms of PGF and TNFAIP2 genes related to cervical cancer risk among Uygur females from China

SNP ID

Model

Genotype

I-II

III-IV

OR (95%CI)

p

rs8019391

Allele

C

110

220

1.00

4.58 × 10−4

T

50

44

2.27 (1.43–3.62)

Codominant

CC

37

91

1.00

 

CT

36

38

2.34 (1.29–4.25)

0.005

TT

7

3

5.76 (1.41–23.52)

0.015

Dominant

CC

37

91

1.00

0.001

CT-TT

43

41

2.59 (1.46–4.60)

Recessive

CC-CT

73

129

1.00

0.045

TT

7

3

4.13 (1.04–16.45)

Log-additive

2.36 (1.45–3.86)

< 0.001

  1. SNP single nucleotide polymorphism, OR odds ratio, 95% CI 95% confidence interval
  2. p values were calculated by logistic regression analysis with adjustments for age
  3. p < 0.05 indicates statistical significance